MSP Recovery Claims, Series LLC et al v. Bayer Healthcare Pharmaceuticals, Inc. et al
| MSP Recovery Claims, Series LLC, MAO-MSO Recovery II LLC and MSPA Claims 1, LLC |
| Janssen Pharmaceuticals, Inc., McKesson Corporation, Janssen Research & Development, LLC, Johnson & Johnson, Bayer AG, Merck Sharp & Dohme Corporation, Bayer Healthcare Pharmaceuticals, Inc. and Bayer Corporation |
| 0:2019cv00478 |
| February 27, 2019 |
| US District Court for the District of Minnesota |
| John R Tunheim |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 7, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 29 (Text-Only) COUNSEL PLEASE NOTE: This docket contains pleadings and orders pertaining to this case only and some, but not all, orders from the master case file In re: Fluoroquinolone Products Liability Litigation, 0:15-md-2642 (JRT). Counsel shall read and comply with all Pretrial Orders filed in this master case. Pleadings filed and orders issued in the master case may be accessed through the master docket sheet at 0:15-md-2642-JRT. Additionally, access to Pretrial Orders, minutes, transcripts, and other documents issued in the master case may be found on the Fluoroquinolone MDL website at: #http://www.mnd.uscourts.gov/MDL-Fluoroquinolone/index.shtml. (lmb) |
Filing 28
PROTECTIVE ORDER. Signed by Chief Judge John R. Tunheim on 4/25/2016. (lmb)
|
| Filing 27 Case transferred in from District of Florida Southern; Case Number 1:18-cv-24625. Original file certified copy of transfer order and docket sheet received. Case assigned to Chief Judge John R. Tunheim per MDL List. |
| Filing 26 TRANSFER ORDER (Dated: 2/6/2019) transferring case to the District of Minnesota re: MDL 2642 for consolidated pretrial proceedings pursuant to 28 USC 1407 and assigned to the Honorable John R. Tunheim. (Signed by Sarah S. Vance, Chair). (vjk)[Transferred from Florida Southern on 2/27/2019.] |
| Filing 25 Courtesy Copy of TRANSFER ORDER (Dated 2/6/2019) transferring case to the District of Minnesota re: MDL 2642 for consolidated pretrial proceedings pursuant to 28 USC 1407 and assigned to the Honorable John R. Tunheim. (Signed by Sarah S. Vance, Chair). (Awaiting certified copy from the transferee court). (mc) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 24 SUMMONS (Affidavit) Returned Executed on #1 Notice of Removal (State Court Complaint), with a 21 day response/answer filing deadline by MAO-MSO Recovery II LLC, MSPA CLAIMS I, LLC, MSP Recovery Claims, Series LLC. Bayer AG served on 1/16/2019, answer due 2/6/2019. (Ruiz, John) [Transferred from Florida Southern on 2/27/2019.] |
|
Filing 23
Second Order Staying And Administratively Closing CasePending Potential Transfer To MDL No. 2642, granting #19 Motion for Reconsideration ; granting in part and denying in part #22 Motion for Extension of Time to File. Defendants must respond to thecomplaint within twenty-one days. Signed by Judge Robert N. Scola, Jr on 01/10/2019. See attached document for full details. (jao) [Transferred from Florida Southern on 2/27/2019.]
|
| Closing Case per order on DE #23 (jao) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 22 Amended MOTION for Extension of Time to File Response/Reply/Answer as to #1 Notice of Removal (State Court Complaint), by Bayer Corporation, Bayer Healthcare Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, McKesson Corp., Merck Sharp & Dohme Corporation. (Attachments: #1 Exhibit 1)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 21 RESPONSE to Motion re #19 Defendant's MOTION for Reconsideration re #16 Order Reopening Case,, Order Referring Case to Magistrate Judge, filed by MAO-MSO Recovery II LLC, MSP Recovery Claims, Series LLC, MSPA CLAIMS I, LLC. Replies due by 1/14/2019. (Ruiz, John) [Transferred from Florida Southern on 2/27/2019.] |
|
Filing 20
PAPERLESS ORDER: To expedite the briefing scheduling, the Court resets the response deadline to #19 the Defendants' motion for reconsideration of the order reopening this case. The Plaintiff must respond to the motion for reconsideration on or before January 7, 2019. Signed by Judge Robert N. Scola, Jr. on 1/4/2019. (kbe) [Transferred from Florida Southern on 2/27/2019.]
|
| Filing 19 Defendant's MOTION for Reconsideration re #16 Order Reopening Case,, Order Referring Case to Magistrate Judge, by Bayer Corporation, Bayer Healthcare Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, McKesson Corp., Merck Sharp & Dohme Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
|
Filing 18
ORDER SETTING DISCOVERY PROCEDURES. Signed by Magistrate Judge Edwin G. Torres on 12/27/2018. See attached document for full details. (mdc) [Transferred from Florida Southern on 2/27/2019.]
|
|
Filing 17
Order Granting Extension of Time to Serve. (The Plaintiffs must serve Bayer AGs domestic registered agent on or before January 18, 2019.) Signed by Judge Robert N. Scola, Jr on 12/21/2018. See attached document for full details. (jao) [Transferred from Florida Southern on 2/27/2019.]
|
|
Filing 16
Order Reopening Case and Requiring Discovery And Scheduling Conference And Order Referring All Non-Dispositive Pretrial and Discovery Matters To The Magistrate Judge. Signed by Judge Robert N. Scola, Jr on 12/21/2018. See attached document for full details. (jao) [Transferred from Florida Southern on 2/27/2019.]
|
| Filing 15 MOTION for Extension of Time to serve the Complaint on Defendant Bayer AG Opposed by MAO-MSO Recovery II LLC, MSP Recovery Claims, Series LLC, MSPA CLAIMS I, LLC. Responses due by 1/2/2019 (Attachments: #1 Text of Proposed Order)(Ruiz, John) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 14 Supplemental RESPONSE to #13 Response/Reply (Other), by Bayer AG, Bayer Corporation, Bayer Healthcare Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson. (Attachments: #1 Exhibit 1)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 13 Defendant's RESPONSE to #12 Notice (Other) In Opposition to Plaintiffs' Notice of Denial of Transfer to MDL No. 2642 by Bayer AG, Bayer Corporation, Bayer Healthcare Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 12 NOTICE by MAO-MSO Recovery II LLC, MSP Recovery Claims, Series LLC, MSPA CLAIMS I, LLC re #10 Order on Motion to Stay, 11 MDL Conditional Transfer Order, (Ruiz, John) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 11 TEXT ONLY ENTRY - NOTICE TO COUNSEL - The Clerk of the Panel has determined the listed action(s) is not appropriate for inclusion in this MDL. See Rule 7.1(b)(i). FLS/1:18-cv-24625. Signed by Clerk of the Panel Jeffery N. Luthi on 11/8/2018. Associated Cases: MDL No. 2642, FLS/1:18-cv-24625 (mc) [Transferred from Florida Southern on 2/27/2019.] |
|
Filing 10
Order Granting Stay And Administratively Closing Case Pending Potential Transfer To MDL No. 2642, granting #7 Motion to Stay. Closing Case. Signed by Judge Robert N. Scola, Jr on 11/7/2018. See attached document for full details. (pes) [Transferred from Florida Southern on 2/27/2019.]
|
| Filing 9 Unopposed MOTION for Extension of Time to Respond to Plaintiffs' Complaint for Pure Bill of Discovery filed jointly by Bayer Corporation, Bayer Healthcare Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, McKesson Corp., Merck Sharp & Dohme Corporation. Responses due by 11/21/2018 (Attachments: #1 Text of Proposed Order)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 8 Corporate Disclosure Statement by Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson (Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 7 Unopposed MOTION to Stay Pending MDL Transfer by Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson. Responses due by 11/20/2018 (Attachments: #1 Text of Proposed Order)(Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 6 Notice of Pending, Refiled, Related or Similar Actions by Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson (Kruppa, Andrew) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 5 Clerks Notice of Docket Correction: Disregard Clerks Notice of Docket Corrections re DE 3 and 4 as they were entered in error. (jao) Modified text on 11/5/2018 (jc). [Transferred from Florida Southern on 2/27/2019.] |
| Filing 4 Clerks Notice to Filer re: Electronic Case. Party(ies) Improperly Formatted. The Filer failed to enter the party name(s) in accordance with the CM/ECF Format for Adding Parties for Attorneys Guide. The correction was made. It is not necessary to re-file the document. (jao) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 3 Clerks Notice to Filer re: Electronic Case. Alias Not Added. The Filer failed to add the alias information for the party(ies). The correction was made. It is not necessary to re-file this document. (jao) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 2 Clerks Notice of Judge Assignment to Judge Robert N. Scola, Jr. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Edwin G. Torres is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. (jao) [Transferred from Florida Southern on 2/27/2019.] |
| Filing 1 NOTICE OF REMOVAL (STATE COURT COMPLAINT - Complaint for Pure Bill of Discovery) Filing fee $ 400.00 receipt number 113C-11132609, filed by Janssen Research & Development, LLC, Johnson & Johnson, Janssen Pharmaceuticals, Inc.. No Answer and/or Motion to Dismiss Filed. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Kruppa, Andrew) Modified on 11/5/2018 (jao). [Transferred from Florida Southern on 2/27/2019.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Minnesota District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
